RNTX – rein therapeutics, inc. (US:NASDAQ)

DELAYED


Volume Shares
1 Day Range
Volume Ratio
52 Week High
52 Week Low


VWAP
Today’s Volatility
20 Day Volatility
Open
Prior Close

YTD

1 Day

RNTX

SPY

QQQ

Swipe to see more

Main News & Impact Reports

Date

Time

Symbol

Headline

Impact

1/21

11:17 am

rntx

Rein Therapeutics (NASDAQ:RNTX) had its "hold" rating reaffirmed by analysts at Brookline Capital Management.

High Report

Rein Therapeutics (NASDAQ:RNTX) had its "hold" rating reaffirmed by analysts at Brookline Capital Management.

Report

1/21

10:12 am

rntx

Rein Therapeutics (NASDAQ:RNTX) was downgraded by analysts at Citigroup Inc. to a "hold" rating.

Medium Report

Rein Therapeutics (NASDAQ:RNTX) was downgraded by analysts at Citigroup Inc. to a "hold" rating.

Report

1/20

08:00 am

rntx

Rein Therapeutics Receives Orphan Drug Designation from European Medicines Agency for Lead Drug Candidate in Idiopathic Pulmonary Fibrosis

High Report

Rein Therapeutics Receives Orphan Drug Designation from European Medicines Agency for Lead Drug Candidate in Idiopathic Pulmonary Fibrosis

Report

12/14

01:26 am

rntx

Rein Therapeutics (NASDAQ:RNTX) was downgraded by analysts at Wall Stree

Medium Report

Rein Therapeutics (NASDAQ:RNTX) was downgraded by analysts at Wall Stree

Report

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.